The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© KYODOEisai, Biogen apply for Alzheimer's drug approval in Japan
TOKYO©2024 GPlusMedia Inc.
The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© KYODO
4 Comments
Matchpoint
Good luck guys.
Luis David Yanez
Yet another anti amyloid beta drug, so I don't expect it to do much.
virusrex
Your own source clearly says the problem is with research of one single kind of plaque, not with the whole amyloid theory of the disease, and that other groups have produced evidence of this relationship.
Not to mention the second reference completely depends on amyloid plaques to be of relevance, which again contradicts the point you are trying to make. Heavy metals are naturally present in the brain and their association with the amyloid plaques is far from being proved important, much less causative of the disease, it could be as important as the change of pigmentation of the skin on liver diseases, not a cause but an effect of the real pathologic processes.